コンテンツへスキップ
Merck
  • Ornithine-A urea cycle metabolite enhances autophagy and controls Mycobacterium tuberculosis infection.

Ornithine-A urea cycle metabolite enhances autophagy and controls Mycobacterium tuberculosis infection.

Nature communications (2020-07-17)
Ramya Sivangala Thandi, Rajesh Kumar Radhakrishnan, Deepak Tripathi, Padmaja Paidipally, Abul K Azad, Larry S Schlesinger, Buka Samten, Sachin Mulik, Ramakrishna Vankayalapati
要旨

Macrophages are professional phagocytes known to play a vital role in controlling Mycobacterium tuberculosis (Mtb) infection and disease progression. Here we compare Mtb growth in mouse alveolar (AMs), peritoneal (PMs), and liver (Kupffer cells; KCs) macrophages and in bone marrow-derived monocytes (BDMs). KCs restrict Mtb growth more efficiently than all other macrophages and monocytes despite equivalent infections through enhanced autophagy. A metabolomics comparison of Mtb-infected macrophages indicates that ornithine and imidazole are two top-scoring metabolites in Mtb-infected KCs and that acetylcholine is the top-scoring in Mtb-infected AMs. Ornithine, imidazole and atropine (acetylcholine inhibitor) inhibit Mtb growth in AMs. Ornithine enhances AMPK mediated autophagy whereas imidazole directly kills Mtb by reducing cytochrome P450 activity. Intranasal delivery of ornithine or imidazole or the two together restricts Mtb growth. Our study demonstrates that the metabolic differences between Mtb-infected AMs and KCs lead to differences in the restriction of Mtb growth.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
塩化アンモニウム, for molecular biology, suitable for cell culture, ≥99.5%
Sigma-Aldrich
6-[4-(2-ピペリジン-1-イルエトキシ)フェニル]-3-ピリジン-4-イルピラゾロ[1,5-a]ピリミジン, ≥98% (HPLC)
Sigma-Aldrich
AICAR, ≥98% (HPLC), powder
Sigma-Aldrich
ラパマイシン, Ready Made Solution, 2.5 mg/mL in DMSO (2.74 mM), from Streptomyces hygroscopicus
Sigma-Aldrich
バフィロマイシン A1 レディーメイド溶液, 0.16 mM in DMSO, from Streptomyces griseus
Sigma-Aldrich
AMPK Inhibitor, Compound C, AMPK Inhibitor, Compound C, CAS 866405-64-3, is a cell-permeable compound that inhibits KDR/VEGFR2, ALK2/BMPR-I, and AMPK kinase activities (IC₅₀ = 25.1, 148, and 234.6 nM, respectively).